NIH Seeks Clinical Trial Data For Unapproved Products
The National Institutes of Health on Tuesday proposed requiring drug and device makers to start disclosing clinical trial results for unapproved products, a highly significant expansion of reporting obligations....To view the full article, register now.
Already a subscriber? Click here to view full article